DIGESTION AIDS MARKET ANALYSIS

Market News

The changing lifestyle and diet is leading to digestive disorders in millions of people worldwide. Increasing awareness regarding gastrointestinal health, fitness, and overall wellbeing is driving the digestive aids market growth. Digestive aids are the supplements used to improve digestion and help in breakdown of consumed food particles. Digestive aids help in treating problems such as constipation, gas, acidity, Gastro-esophageal Reflux Disease (GERD), irritable bowel syndrome, etc. Digestion aids products include prebiotics, probiotics, and digestive enzymes. Enzymes such as lactases, lipases, proteases are marketed as dietary supplements. New lactose free products are gaining significant traction as compared to traditional digestive aids, which can be used for the population suffering from lactose intolerance.

Digestion aids market revenue is expected to witness significant growth, owing to increasing number of new product launches for digestive health in children. For instance, in July 2017, Alcresta Therapeutics received 510(K) clearance from the U.S. Food and Drug Administration (FDA) for the use of RELiZORB in children. RELiZORB is used for Pancreatic and Gastric disorders in both children and adults.

Asia Pacific digestion aids market revenue is expected to witness significant growth owing to increasing consumption of probiotics, prebiotics and new launches of digestion aids. For instance, in February 2018, Yakult Danone launched a new version of signature probiotic drink in India. The new formulation contains vitamin D and E, as well as Yakult’s trademark Lactobacillus casei strain Shirota (LcS).